Advanced Ophthalmology Technologies Market Statistics
The global advanced ophthalmology technologies market is projected to surge at a remarkable rate of CAGR of 10.61%, witnessing a valuation of USD 14, 411.56 mn by the end of 2027, as compared to its valuation of USD 7,841.76mn in 2020.
The ophthalmology market has witnessed tremendous improvement in the past few years, thanks to emerging new technologies.
The rise in the geriatric population is expected to drive the global advanced ophthalmology technologies market during the forecast period.
Drivers and Restraints
The global advanced ophthalmology technologies market is anticipated to witness staggering growth, owing to the increasing geriatric population.
Eye diseases are not new, neither they are specific to any age, vision impairment or diseases that are sometimes genetic and or caused by some existing health factors. The increase in such cases with vision challenges is expected to drive the advanced ophthalmology technologies market.
The growing cases of cataracts, glaucoma, etc. are anticipated to expand the demand for advanced ophthalmology technologies in the following years.
The rising awareness and initiatives undertaken by the government to control visual impairments and bring relief to patients are expected to boost the advanced ophthalmology technologies market.
Although advanced ophthalmology technologies are gaining traction in the global market, there are certainly certain challenges that may dampen the market.
The high cost of ophthalmology surgeries and devices is anticipated to hinder the growth during the forecast period.
Further, the lack of skilled ophthalmologists and the lack of advanced ophthalmology facilities in rural and semi-rural areas are expected to hamper the growth of the global advanced ophthalmology technologies market.
Despite all the restraints, the growing need for accurate and timely diagnosis of vision issues and diseases is expected to drive the demand for advanced ophthalmology technologies.
Opportunities and Trends
The rising trend of early eye diseases and vision impairment due to various health factors is expected to boost the market potential for advanced ophthalmology technologies.
Rising awareness among people and timely eye check-ups are expected to improve the growth potential for the advanced ophthalmology market.
The ophthalmology sector continues to witness a significant growth opportunity due to advanced development in the field leveraging technology to its best.
In one of the recent developments, VisionCare ophthalmology technologies have received approval from FDA for an implantable monocular miniature telescope which is designed to treat patients with end-stage macular degeneration. Such developments are expected to upsurge the growth opportunities in the coming years.
Advancements such as the orbital tissue expander, developed by Dr David Tse and manufactured by Innovia LLC received Medical Design Excellence Award in 2010. This product is made of biocompatible and inflatable silicon addressing vision impairment due to trauma or infection.
This technological advancement that focuses on treating from simple eye issues to complex surgeries and incurable diseases in vision has paved the way for growth potential in the advanced ophthalmology technologies market.
The growing adoption of artificial intelligence is leading the way to boost the advanced ophthalmology technologies market, owing to the development of products such as Robot Scanner that detects several eye diseases including early signs of macular degeneration.
Product Segment Overview
The global advanced ophthalmology technologies market is broadly bifurcated into types and end-users.
Based on the types, the market is further segmented into diagnostic and therapeutic. So far, the diagnostics segment held a major share in the advanced ophthalmology technologies market.
The same diagnostics segment is expected to hold the largest share in the market during the forecast period, owing to increasing awareness, a rise in demand for accurate diagnosis, and the availability of advanced diagnostic tools.
Further, the government’s initiatives for ophthalmology care and awareness are resulting in an increase in demand for diagnostic.
Among the end-users, the global advanced ophthalmology technologies market is segmented into hospitals, ophthalmic clinics, and ambulatory surgical centres
The hospital sector had been ruling the market so far and is expected to continue the same during the forecast period.
The installation of advanced ophthalmic devices is easy and possible in the hospital infrastructure. Some of these devices are ophthalmic ultrasound imaging systems, optical biometry systems, and optical coherence tomography scanners.
Regional Market Overview
In terms of geographical dominance, North America held a lion’s share in the advanced ophthalmology technologies market and is anticipated to continue its dominance over the forecast period as well.
The availability of advanced technology, a large patient pool, and the presence of major key players are expected to drive the market in the region.
Further, innovative launches such as the orbital tissue expander are expected to drive growth opportunities in the market.
After, North America, it is Europe that shows a good growth opportunity and has held a second place in the past. The rising number of age-related vision impairment, availability of skilled ophthalmologists, and rise in the number of ophthalmic clinics are expected to drive the growth in the region.
Lately, the Asia Pacific region has been showing an impressive growth opportunity in the region, owing to the huge patient population in counties like China and India, increasing awareness about vision health, government initiatives, and increasing expenditure on health infrastructure.
Competitive Landscape
 The global advanced ophthalmology technologies market is highly competitive due to the presence of stalwarts in the market.
These market players are constantly focusing on introducing innovative products and ophthalmology devices. The recent one is VisionCare’s implantable miniature telescope.
The market players are also expected to adopt new strategies such as collaboration, mergers, and acquisitions to penetrate deeper into the market and expand their presence.
Advanced Ophthalmology Technologies Market Key Players
- Johnson & Johnson Services
- Ziemer Ophthalmic Systems Ltd
- Bausch & Lomb Incorporated
- Novartis AG
- CooperVision
- Alcon Vision LLC
- Carl Zeiss Meditec AG
- Nidek Co. Ltd
- Topcon Corporation
Product/Type Disposition (Revenue in USD million)
Diagnostic
- Optical Coherence Tomography Scanners
- Ophthalmic Ultrasound Imaging Systems
- Wavefront aberrometers
- Optical Biometry System
- Corneal Topography Systems
- Specular Microscopes
- Others
 Therapeutic
- Ophthalmic Lasers
- Surgical Devices
 End Users Dispositions (Revenue in USD million)
- Hospitals
- Ophthalmic Clinics
- Ambulatory Surgical Centers
- Others
Regional Disposition
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Frequently Asked Questions in Advanced Ophthalmology Technologies Market
- What are the growth opportunities in the advanced ophthalmology technologies market?
- How would the advanced ophthalmology technologies market grow and at what rate?
- What are the challenges in the advanced ophthalmology technologies market?
- How would the hospital segment impact the advanced ophthalmology technologies market?
- Why North America is supposed to hold the largest share in the market?
Table Of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Advanced Ophthalmology Technologies Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Advanced Ophthalmology Technologies Market Analysis 2017-2021 and Forecast 2022-2032, By Product/Type Disposition
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product/Type Disposition, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product/Type Disposition, 2022-2032
5.3.1. Diagnostic
5.3.1.1. Optical Coherence Tomography Scanners
5.3.1.2. Ophthalmic Ultrasound Imaging Systems
5.3.1.3. Wavefront Aberrometers
5.3.1.4. Optical Biometry System
5.3.1.5. Corneal Topography Systems
5.3.1.6. Specular Microscopes
5.3.1.7. Others
5.3.2. Therapeutic
5.3.2.1. Ophthalmic Lasers
5.3.2.3. Surgical Devices
5.4. Y-o-Y Growth Trend Analysis By Product/Type Disposition, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product/Type Disposition, 2022-2032
6. Global Advanced Ophthalmology Technologies Market Analysis 2017-2021 and Forecast 2022-2032, By End Users Dispositions
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End Users Dispositions, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End Users Dispositions, 2022-2032
6.3.1. Hospitals
6.3.2. Ophthalmic Clinics
6.3.3. Ambulatory Surgical Centres
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By End Users Dispositions, 2017-2021
6.5. Absolute $ Opportunity Analysis By End Users Dispositions, 2022-2032
7. Global Advanced Ophthalmology Technologies Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. East Asia
7.3.5. South Asia
7.3.6. Oceania
7.3.7. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Advanced Ophthalmology Technologies Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Product/Type Disposition
8.2.3. By End Users Dispositions
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product/Type Disposition
8.3.3. By End Users Dispositions
8.4. Key Takeaways
9. Latin America Advanced Ophthalmology Technologies Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Argentina
9.2.1.4. Chile
9.2.1.5. Peru
9.2.1.6. Rest of Latin America
9.2.2. By Product/Type Disposition
9.2.3. By End Users Dispositions
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product/Type Disposition
9.3.3. By End Users Dispositions
9.4. Key Takeaways
10. Europe Advanced Ophthalmology Technologies Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. U.K.
10.2.1.5. Spain
10.2.1.6. Russia
10.2.1.7. BENELUX
10.2.1.8. Rest of Europe
10.2.2. By Product/Type Disposition
10.2.3. By End Users Dispositions
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product/Type Disposition
10.3.3. By End Users Dispositions
10.4. Key Takeaways
11. East Asia Advanced Ophthalmology Technologies Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.2. By Product/Type Disposition
11.2.3. By End Users Dispositions
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product/Type Disposition
11.3.3. By End Users Dispositions
11.4. Key Takeaways
12. South Asia Advanced Ophthalmology Technologies Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Thailand
12.2.1.3. Malaysia
12.2.1.4. Indonesia
12.2.1.5. Rest of South Asia
12.2.2. By Product/Type Disposition
12.2.3. By End Users Dispositions
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product/Type Disposition
12.3.3. By End Users Dispositions
12.4. Key Takeaways
13. Oceania Advanced Ophthalmology Technologies Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Product/Type Disposition
13.2.3. By End Users Dispositions
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product/Type Disposition
13.3.3. By End Users Dispositions
13.4. Key Takeaways
14. MEA Advanced Ophthalmology Technologies Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC
14.2.1.2. Rest of MEA
14.2.2. By Product/Type Disposition
14.2.3. By End Users Dispositions
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product/Type Disposition
14.3.3. By End Users Dispositions
14.4. Key Takeaways
15. Key Countries Advanced Ophthalmology Technologies Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Product/Type Disposition
15.1.2.2. By End Users Dispositions
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Product/Type Disposition
15.2.2.2. By End Users Dispositions
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Product/Type Disposition
15.3.2.2. By End Users Dispositions
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Product/Type Disposition
15.4.2.2. By End Users Dispositions
15.5. Argentina
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Product/Type Disposition
15.5.2.2. By End Users Dispositions
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. Â By Regional
16.3.2. Â By Product/Type Disposition
16.3.3. Â By End Users Dispositions
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Johnson & Johnson Services
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Ziemer Ophthalmic Systems Ltd
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Bausch & Lomb Incorporated
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Novartis AG
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. CooperVision
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Alcon Vision LLC
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Carl Zeiss Meditec AG
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Nidek Co. Ltd
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Topcon Corporation
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Request Free Sample
